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Introduction
Our understanding of the biological roles of complex carbohydrates is currently taking a quantum leap. Initially viewed to store energy and confer rigidity to cell walls, the sugars' unsurpassed versatility for generating structural variability of oligomers is being delineated as a platform for coding, with receptors (lectins) reading and translating sugar-encoded messages into cellular effects.
1 Fittingly, cases of functional orchestration of glycan/lectin expression, e.g. in inflammation or by a tumor suppressor, are unravelled, stimulating project lines to define the diagnostic/prognostic potential of carbohydrate-protein interactions. 2 Moving on from work with plant lectins as models, the quest to explain the inherent specificity and selectivity of the interplay of tissue lectins with their (cognate) counter-receptors has inspired efforts to shape synthetic binding partners, in terms of the structure of headgroups and their spatial presentation.
3
The asialoglycoprotein receptor on hepatocytes has become a role model with its preference for trivalent binding partners, with its three contact sites separated by about 15 Å, 22 Å and 23 Å. 3a Our work in this area has thus far focused on bi-to tetravalent compounds, where the headgroups were grafted to terephthalamide, N,N'-diglucosylterephthalamide, ditriazole and glycophane and triazole containing scaffolds. 4 Terephthalamide was found to be a scaffold suited for presenting carbohydrate ligands to plant and human lectins, as exemplified by the bioactivity of compound 1. 4a,b This glycocluster 1, which is a constrained compound, features a distance of 7 to 8 Å between its two sugar headgroups (intersugar or interheadgroup distance). 4a In order to explore structurebioactivity relationships using such glycoclusters as tools, we prepared compounds 2-7
(Chart 1) as a set of analogues of 1, with lactose as the headgroup. Beside the terephthalamide scaffold in 2, we generated acceptors for ligands based on tertiary amides of oxalic acid (3), isopthalic acid (6) and 2,6-napthalic acid (5). In these three cases, the interheadgroup distance is varied, with possibly the headgroup orientation also being varied, while maintaining the sugar and the acetylglycine residue bonded to the nitrogen atoms. In compounds 2 and 4, a t-butyl residue was incorporated instead of the acetate residue present in compounds 3, 5 and 6; it was anticipated that this modification would give an indication as to whether the group attached to the anomeric nitrogen atom has an effect on the reactivity to a lectin. To assess the impact of the Chart 1. Structure of glycoclusters 1-10 2. Results and discussion
Synthesis of the glycoclusters
The preparation of the bivalent glycoclusters 1-6 with lactose as headgroup started from the lactosyl samine 11 (Scheme 1) and involved the Ugi reaction. The reaction of 11 with formaldehyde, terephthalic acid and methyl isocyanoacetate gave 1 after deacetylation, as earlier described.
11
When 11 was reacted with oxalic acid, 2,6-naphthalenedicarboxylic acid and isophthalic acid, respectively, in the presence of formaldehyde and methyl isocyanoacetate, and the acetyl groups removed, then compounds 3, 5 and 6 were obtained. When t-butyl isocyanide was reacted with lactosamine 1, formaldehyde and terephthalic acid or isophthalic acid in methanol, the bivalent compounds 2 and 4 resulted after deacetylation.
Scheme 1. Synthesis of bivalent glycoclusters 1-6
The syntheses of bivalent glycoclusters presenting as headgroup the trisaccharide fucosyl lactose were next carried out (Scheme 2 & Scheme 3). Firstly, the fucosylated azide 12 was prepared as previously described.
4d
This azide was used in coppercatalysed azide alkyene cycloaddition reactions 12, 13 with 14 and 15 to give, after deacetylation and subsequent HPLC-based purification, 8 and 9, respectively. Although the azide 12 contained a small amount of the -anomer (<6%), it was possible to remove the cycloaddition products that resulted from the presence of this anomer by careful chromatography prior to the final deprotection step. Next, catalytic hydrogenation of 12 resulted in the 2'-O-fucosyl lactosamine 13 (Scheme 2), which when used in a coupling reaction with terephthaloyl chloride in the presence of DIPEA and followed by deacetylation was turned into 10. Since the glycosyl amine 13, formed by the reduction of the azide, contained a small amount of its α-anomer (<10%), a mixture of diamides was obtained from the coupling reaction with the terephthaloyl chloride. Purification by HPLC was necessary in order to obtain 10 as a single product.
Scheme 2 Synthesis of 8-10
Since the Ugi reactions of 11 were successful, we also were interested to try to prepare the fucosyl lactose analogue of 1 from 13. However, the Ugi reaction did not succeed for peracetylated compound 13. We suggest that the acetylated 2'-O-fucosyl residue is sufficiently electron withdrawing to reduce the nucleophilicity of the anomeric amine group of 13, even though it is remote from the amine. To solve this problem the Ugi reaction of amine 18 was carried out instead. Compound 16 was treated with saturated solution of ammonium hydrogen carbonate to give 17. Next, the amine group of 17 was temporarily protected by a treatment with N-(9-fluorenylmethoxycarbonyloxy)-succinimide (FmocOSu) in pyridine and the free hydroxyl groups were acetylated by adding acetic anhydride. The Fmoc was removed thereafter using morpholine in DMF to
give the fucosyl lactosamine 18. This was subsequently reacted with formaldehyde, methyl isocyanoacetate, and terephthalic acid to yield a diamide. The protecting groups were removed by Zemplén deacetylation and hydrogenolysis to give rise to 7 (Scheme 6).
Scheme 3 Synthesis of 7

Structural analysis and molecular modelling
Compounds 1-7 and 10 are divalent glycosyl amides, structurally related to terephthalamides described previously. 11 In 1-7, the amides are tertiary amides, whereas 10 harborsed secondary amides. In terms of amide configuration, the amides in 10 are trans amides (or Z amides). This term trans is applied as in peptide chemistry.
Compound 10 shows one set of signals in the NMR spectrum, and the chemical shift of
the anomeric proton appears at  5.84 as a doublet with a coupling constant of J = 9.3 comparison with related secondary amides. 11 However, and as shown previously for tertiary terephthalamides, the tertiary amides in 1-7 adopt configurations where the cis (E) amide is preferred. The NMR spectra show two signal sets for all these compounds.
For example, for 2 (Fig. 3 ) the anomeric proton for the cis (or E) amide appears at  4.67 (J = 8.8 Hz), whereas that for the trans amide was observed at  5.62 (J = 9.3 Hz). 
cis-cis).
The extended cis-cis structure is considered to be more relevant for binding to lectins, because headgroups might be too close for reactivity when stacked. It is also possible that lectins could bind to their ligand in the EZ or cis-trans structure, which is present to a lesser degree in solution. Dynamic transition to the EZ conformer is possible in the equilibrium as a result of amide bond rotation, and there is evidence that this exchange can take place for compounds related to 1-7. 11 While the trans-trans (ZZ) isomer for compounds 1-7 (not shown) could also be adopted, it appears to be present at concentrations too low to be detected by NMR. Based on the NMR data for compounds 1-7 we conclude that the major structural isomer is cis-cis or EE. Assuming that the extended cis-cis structure is more relevant than the stacked cis-cis structure and cis-trans structures for presenting the headgroup for binding to a lectin, we next carried out molecular dynamics simulations using Macromodel 8.0 (Schrödinger Inc., LLC, New York, NY, USA), to supplement our previous studies of divalent compounds. 4a The main purpose of this work is to estimate distances between the carbohydrate headgroups and respective orientations. Models were built for the compounds 1-3 and 5-6, and each compound was treated equally.
Stochastic dynamics was applied to the selected structure at 300 K with an equilibration time of 1 µns and a time step of 1.5 fs using the OPLS-AA force field in the gas phase.
A simulation was carried out in Macromodel for compound 2 using the GB/SA effective solvent model for water (not explicit water) and no major differences were observed between the gas phase simulation of 2 and ing the GB/SA effective water model for 2.
During each of the subsequent simulations 100-200 structures were sampled and an internal coordinate system was used to define spatial parameters for these structures.
This system firstly involves measuring the distances for the sampled structures between the anomeric carbon atoms of the glucose unit in the disaccharide (in Å) to give the interheadgroup distance. In addition, two dihedral angles were measured, a core dihedral and a galactose dihedral, for the sampled structures, providing parameters relevant to the interheadgroup orientation, and these are defined in the top part of Fig.   4 . Scatter plots were generated using the data obtained, and these are also shown in Fig. 4 . These plots can be considered representative of the spatial arrangements between the lactose headgroups accessible during the simulations, which were run at identical conditions.
As can be seen, by comparing data for compounds 1 and 2, the measured galactose and core dihedrals did not vary significantly, indicating that the relative orientations between the two potential contact sites for galectins are similar for these compounds and apparently not greatly influenced by replacing the terminal acetate with the t-butyl group. Similarly, the distance between the two disaccharides did not change noticeably, averaging between 7-8 Å for both compounds during the simulations, as can also be expected for compound 7. For 6, which has the isophthalic acid, similar interlactose distances to compounds 1 and 2 were observed, but there was more flexibility in Formatted: Font: Bold interheadgroup orientation, as can also be expected for the structurally similar compound 4. With regard to compound 5, which has naphthalene rather than benzene, the distance between the lactose residues is increased, as would be expected, and this varied between 9-10 Å during the simulation. Molecular dynamics simulations for compound 10 was not carried out but, on the basis of studies with a related lactose diamide, 4a the distances between the residues would be expected to be 10 Å and similar to 5. The interheadgroup orientation in 5 was similar to that found in compounds 1 and 2. Coming to the ditriazoles, the distance between the two trisaccharides in 8
would be expected to approximate to 13 Å, whereas compound 9 is more flexible with distances of up to 16-17 Å being possible. At the other side of the range of distances, for the oxalic acid derivative 3, its lactose residues were separated by 3-4 Å and the interheadgroup dihedrals were also significantly different. 
Analysis of inhibitory potency
In the first type of assay, a glycoprotein (asialofetuin with up to nine LacNAc termini in the three triantennary complex-type N-glycans) was adsorbed to the plastic surface of microtiter plate wells, a matrix for carbohydrate-dependent binding of Gal-4. Binding was saturable, dependent on the presence of the terminal galactose moieties of the N-glycans and was blocked completely by an excess of hapten (lactose), for all galectin proteins tested (not shown). Titrations at an assay setting in the linear range of the ODresponse with increasing concentrations of the test compounds determined the concentration to reduce extent of the signal by 50% (IC 50 -value), a relative measure of the capacity to interfere with glycan-lectin interaction (for representative cases, please see Fig. 6 ). As given in Table 2 , Gal-4 binding was rather effectively inhibited by the bivalent compounds, extending the previously collected evidence with a tertiary terephthalamide (compound 1) and N,N'-diglucosylterephthalamides. 4a The addition of the 1,2-linked fucose moiety to the lactose headgroup expectedly led to an increase in inhibitory potency, from 0.3 mM for lactose in the secondary terephthalamide 4a to 0.05 mM (compound 10). The introduction of the t-butyl group (for compounds 2 and 4) can make a rather minor difference, oxalic acid in the backbone proved rather favourable, compared to isophthalic acid ( Table 2 ). The two ditriazoles with the trisaccharide were the most potent inhibitiors (Table 2) . Overall, the data further substantiate the sensitivity of this lectin to bi-and trivalent glycoclusters, hereby establishing a solid basis to ask the question whether and how linker-length reduction in the tandem-repeat-type lectin will affect the reactivity towards the glycocluster. Two forms of engineered Gal-4 were therefore tested, by maintaining linker parts phylogenetically conserved in mammals (Gal-4V) and by turning Gal-4 into a linkerless, proto-type-like form (Gal-4P) (Fig. 1 ).
The results obtained by testing these two variants under identical conditions clearly showed that: i) reduction of linker length decreased the lectin's susceptibility to the test compounds; and ii) this truncation of the linker and its complete removal led to similar results (Table 2 ). Most conspicuously, the two ditriazoles 8 and 9 dropped markedly in inhibitory capacity, a result definitely warranting confirmation by a different assay type.
However, a special point precludes direct comparability for all data: the interpretation of the data for fucosyl lactose-presenting compounds 7-10 should take into account that the reactivity of Gal-4V to this epitope has been shown to decrease relative to that of the wild-type protein. 5c An impact of the truncation both on affinity and on ligand selection has furthermore been revealed for surface binding to human neuroblastoma cells. 17 To document how a dimeric galectin will react with the glycoclusters we have added CG-1A. The range of IC 50 -values of the two engineered Gal-4 proteins was rather similar to that of this control protein (Table 2 ). Its level of reactivity was in line with previous results for CG-1A and dilactosyl diamides/di-, tri-and tetravalent fucosyl lactosides.
4c,d
In order to exclude the possibility that characteristics inherent to the solid-phase assay underlie the differences seen in Table 2 between the compounds with terephthalic acid vs the 2,6-naphthalic acid cores showed that there no major difference between these scaffolds, also reflecting their rather similar interheadgroup orientation described above. A grading of activities was seen for the trisaccharide-presenting clusters 7, 9 and 10 (Fig. 6C7C) . The tertiary terephthalamide 7 proved very active, as also seen for the ditriazole 9, and, fully in line with a rather low potency of the lactose-presenting secondary terephthalamide in the solid-phase assay, 4a compound 10 was found to be the least active. Its inhibitory capacity was in the range of that for more suited scaffolds 2 and 5 presenting lactose instead of the trisaccharide (Fig. 6B7B,C) .
When testing labeled Gal-4V, inhibition by free sugars corroborated the comparatively reduced level of reactivity to the trisaccharide mentioned above (Fig. 6D7D) . The same applied to the reactivity to the clusters 2 and 5 (Fig. 6E7E, F) . Despite a 3fold higher sugar concentration the extent of inhibition was less for Gal-4V than for Gal-4 binding (Fig. 6B7B, C vs Fig. 76E, F) , as seen in the solid-phase assays ( Table 2) . As similarly seen for the second cell line (Lec2 CHO) and for labeled Gal-4P (not shown), results in both assay types consistently indicated that the linker has a bearing on the lectin's reactivity to bivalent glycoclusters and to the trisaccharide (2'-fucosyl lactose)
headgroup. Evidently, this peptide portion of Gal-4 does more than simply connecting the two CRDs, and there is corroborating evidence for this assumption. By measuringHaving measured the diffusion constant of the proteins, the (counterintuitive)
decrease from 1.02 ± 0.01 to 0.92 ± 0.01 10 -6 cm 2 s -1 by truncation (reducing the molecular mass), along with acquisition of lactose dependence of this parameter, 18 argues in favour of an active role of the linker, above a certain length limit, in making Gal-4 structurally somehow compact.18 In this spatial form, probably with some flexibility to adapt in the presence of bi-to oligovalent ligands, the lectin is more sensitive to the test compounds than its variants. Headgroup distance in the tested range, which covers the distances in biantennary N-glycans, altered sensitivity for Gal-4 to a limited extent, while invariably being less active for Gal-4 after truncation.
Whether a different type of protein processing will also have a bearing on sensitivity was tested in a second system. Galectin-3 is special among galectins due to its N-terminal stalk with the two sites for Ser phosphorylation and the collagen-like repeats, this section connected as tail to the CRD. It is responsible for oligomerization in the presence of polyvalent ligands and high-affinity binding to clustered counterreceptors.
19
In this case, too, removal of a protein part, here the tail, a natural proteolytic process, alters the sensitivity. As shown in Fig. 7 8 for experiments with the wild-type CHO line, CG-3 was much more reactive with test compounds than the truncated version, extending previous observations with, for example, a bivalent glycocluster with triazole linkers that had a more than 2fold higher capacity to interfere with CG-3 binding. 4d The differences noted in the cytofluorimetric assays were in this range (Fig. 87B,D) .
Conclusions
Two factors combine to establish the reactivity of a glycan to a lectin: the structure of the cognate epitope and its spatial presentation. 1 To attain the required high-level specificity and selectivity in counterreceptor selection in vivo the way sites for contact are positioned in lectins is assumed to matter markedly, too. If this is true, glycoclusters should sense engineered changes in lectins, serving as tools for structure-activity correlations. Our data using two engineered Gal-4 variants and a test panel of bivalent glycoclusters revealed special properties for the protein with the natural linker length. Its reduction decreased the susceptibility to glycoclusters in the two binding assays and the reactivity to the H-type trisaccharide, encouraging further testing, e.g. in agglutination assays using glycodendrimersomes. 20 Also considering the results with CG-3, this approach, teaming up protein engineering with glycocluster synthesis and testing, is thus illustrated to be useful on the way to eventually resolve the question on the physiological significance of the length of sequence extension (Gal-3) or linker (Gal-4) in endogenous lectins, for galectins and other lectin families sharing these types of modular design. 
General experimental
Unless otherwise noted, all commercially available compounds were used as provided without further purification. Solvents for chromatography were technical grade.
Petroleum ether 40-60 °C was used for column chromatography and thin layer chromatography (TLC). NMR spectra were recorded (25 °C). The frequency was 500
MHz for 1 H NMR and 125 MHz for 13 CH 2 Cl 2 , MeOH, toluene and THF reaction solvents were used as obtained from a Pure Solv™ Solvent Purification System. Anhydrous DMF, pyridine, and EtOH were used as purchased from commercial suppliers.
Synthetic procedures
Typical procedure for the Zemplén deacetylation The acetylated compound (0.02 mmol) was dissolved in methanol (5 mL), a catalytic amount of NaOMe (0.1 mL of a 0.2 M solution in MeOH) was added and the resulting mixture was stirred for 1 h at room temperature. Amberlite IR-120 (plus) was added, the mixture neutralised and the resin was then removed by filtration and washed with water. Finally, the solvents were removed under diminished pressure and the residue subjected to subsequent chromatographic purification. 
N,N'-Di(β-D-galactopyranosyl-(1→4)-β-D-glucopyranosyl)-N,N'-di[(t-
butylcarbamoyl
[N,N'-Di(β-D-galactopyranosyl-(1→4)-β-D-glucopyranosyl)-N,N'-di(1-methoxycarbonyl)-methylamino-2-oxoethyl]-naphthalene-2,6-dicarboxamide 5
Naphthalene-2,6-dicarboxylic acid (18 
N,N'-Di(β-D-galactopyranosyl-(1→4)-β-D-glucopyranosyl)-N,N'-di[(1-
methoxycarbonyl)-methylamino-2-oxoethyl]isophthalamide 6
Isophthalic acid (20 mg, 0.12 mmol), lactosyl amine 1 20 1 21 (152 mg, 0.24 mmol), and formaldehyde (23 μL of a 37% solution, 0.29 mmol) were suspended in MeOH (5 mL) and the mixture was stirred at room tempeature for 1 h. Methyl isocyanoacetate (23 μL, 0.24 mmol) was then added and the mixture was stirred at room temperature overnight. 4, 170.34, 170.30, 170.0, 169.9, 169.8, 138.7, 138.6, 138.4 (each C), 128.4, 128.3, 128.2, 127.7, 127.6, 127.54, 127.50, 127.3, 100.9, 97.9, 84.9, 79.4, 77.7, 76 91, 20.88, 20.8, 20.7, 20.6, 16.5 (each CH 3 
N,N'-Di[α-L-fucopyranosyl-(1→2)-β-D-galactopyranosyl-(1→4)-β-D-
glucopyranosyl]-N,N'-di[(1-methoxycarbonyl)methylamino-2-oxoethyl]terephthalamide 7
Terephthalic acid (5 mg 99.5, 87.6, 77.5, 76.6, 75.2, 75.1, 74.2, 73.4, 71.6, 69.7, 69.5, 69.0, 68.2, 66.8 
1,4-Di[α-L-fucopyranosyl-(1→2)-β-D-galactopyranosyl-(1→4)-β-D-glucopyranosyl-1,2,3-triazol-4-yl]benzene 8
Compound 12 (130 mg, 145.9 μmol) was dissolved in CH 3 OH-H 2 O (2:1, 12 mL), then 1,4-diethynyl benzene (9.6 mg, 73.0 μmol), sodium ascorbate (5.8 mg dissolved in 1mL H 2 O, 29.2 mol) and CuSO 4 (2.4 mg dissolved in 1mL H 2 O, 14.6 μmol) were subsequently added and the mixture was stirred overnight, after which the solvent was removed and the residue was precipitated by CH 2 Cl 2 (50 mL) and water (15 mL). The organic phase was washed by water (15 mL × 2), dried by Na 2 SO 4 and concentrated. The crude residue was purified by flash chromatography 126.3, 121.3, 100.3, 99.4, 87.4, 78.1, 76.4, 75.2, 74.9, 74.4, 73.5, 72.1, 71.6, 69.6, 69.1, 68.2, 66.9 
1,4-Di[(α-L-fucopyranosyl-(1→2)-β-D-galactopyranosyl-(1→4)-β-Dglucopyranosyl)-1,2,3-triazol-4-ylmethyloxy]benzene 9
Compound 12 (90 mg, 0.10 mmol) was dissolved in CH 3 OH-H 2 O (2:1, 6 mL), then p-bispropargyloxybenzene 21 bispropargyloxybenzene 22 15 (9.4 mg, 0.05 mmol), sodium ascorbate (4 mg dissolved in 1mL H 2 O, 20 μmol) and CuSO 4 (1.6 mg dissolved in 1mL H 2 O, 10 μmol) were subsequently added and the mixture was stirred overnight, after which the solvent was removed and the residue was participated by CH 2 Cl 2 (50 mL) and water (15 mL). The organic phase was washed by water (15 mL × 2), dried by Na 2 SO 4 and concentrated. 7, 170.6, 170.5, 170.3, 170.1, 169.9, 169.8, 169.7, 168.9, 152.8, 145 .0 (each C), 121.2, 115.9, 100.2, 95. 6, 85.8, 76.3, 73.8, 73.4, 71.8, 71.5, 71.0, 70.9, 70.2, 68.0, 67.3, 67.0, 65.0 (each CH), 62.6, 62.1, 60.8 (each CH 2 ), 20.8, 20.70, 20.68, 20.66, 20.65, 20.63, 20.60, 20.2, 15.6 (each CH Na: 1991.6092; Found: 1991.6145 . This intermediate (37 mg, 0.019 mmol) was dissolved in methanol (5 mL) to which a catalytic amount of NaOMe (0.1 mL of a 0.2 M solution in MeOH) was added and the resulting solution was stirred for 1 h at room temperature. Amberlite IR-120 (plus) was added to neutralize pH = 7, after which the resin was removed by filtration and washed with water. The solvent removed under diminished pressure to give 9 after lyophilisation, as an amorphous solid (20 mg, 88%).
[α] 124.4, 116.9, 100.2, 99.3, 87.3, 78.1, 76.3, 75.2, 74.9, 74.4, 73.5, 72.0, 71.6, 69.6, 69.1, 68.1, 66.9 (each CH), 62.0, 61.1, 59.7 74, 170.70, 170.6, 170.34, 170.30, 170.1, 170.03, 170.01, 169.67 (each C), 100.2, 95.5, 85.0, 74.7, 74.0, 73.5, 72.4, 72.0, 71.4, 71.1, 70.7, 68.1, 67.5, 67.1, 64.8 (each CH) , 62.7 (CH 2 ), 60.9 (CH 2 ), 20.92, 20.86, 20.8, 20.67, 20.66, 20.65, 20.63, 20.60, 20.59, 15.53 7, 170.7, 170.6, 170.5, 170.3, 170.2, 170.0, 169.7, 169.6, 165.9, 136.2 (each C), 127.7, 99.9, 95.7, 79.0, 74.9, 74.1, 73.4, 71.7, 71.4, 71.1, 71.0, 70.8, 68.1, 67.4, 67.0, 65.0 (each CH), 62.3 (CH 2 ), 61.0 (CH 2 ), 20.9, 20.78, 20.76, 20.69, 20.67, 20.66, 20.64, 20.60, 15.6 (each CH MeOH) was added and the resulting solution was stirred for 1 h at room temperature.
Amberlite IR-120 (plus) was added to neutralize pH = 7, after which the resin was 99.3, 79.8, 77.0, 76.2, 75.2, 75.1, 73.5, 71.6, 71.5, 69.6, 69.1, 68.1, 66.9 Proteins were produced in the BL21(DE3) pLysS E. coli strain with TB medium (Roth, Karlsruhe, Germany) at 22 °C with optimal yields of 9 mg/L for Gal-4V and 3 mg/L for Gal-4P reached with a final IPTG concentration of 75 µM. Recombinant production of the two CG-3 proteins followed the previously described protocol. 22 10a Quality controls by one-and two-dimensional electrophoresis, gel filtration and haemagglutination to ascertain homogeneity, quaternary structure and activity as well as biotinylation under activity-preserving conditions followed by product analysis to quantify label incorporation and activity assessment were performed as described. 
Solid-phase/cell assays
The plastic surface of microtiter plate wells was coated with the glycoprotein asialofetuin (0.5 µg per well in 50 µl phosphate-buffered saline) overnight at 4 °C, and further processing followed the protocol given in detail previously. 4 Assays were routinely done in triplicates with up to six independent series. Cell binding was measured for human pancreatic carcinoma (Capan-1) cells expressing the tumor suppressor p16 INK4a (kindly provided by K. M. Detjen, Berlin, Germany) 2a 2b as well as with the wild-type (parental)/Lec2 mutant lines of the CHO system (kindly provided by P. Stanley, Bronx, USA). 24 Process steps and controls were performed as described previously.
2ba, 4, 25
Aliquots of cell suspensions at the same passage were routinely processed at least in duplicates, with at least three independent series and standard deviations not exceeding 13.6 % after normalization of data based on internal controls and background values. 
